Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACRV
#3450
Acrivon Therapeutics, Inc. Common Stock
1.5
1
-17.03%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-17.03%
Monthly Change
-23.74%
6 month change
+11.03%
Year Change
-71.51%
Previous Close
1.8
2
Open
1.5
1
Bid
Ask
Low
1.5
1
High
1.5
1
Volume
10
Markets
US Stock Market
Healthcare
ACRV
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Acrivon将在ESGO大会上展示ACR-368子宫内膜癌数据
Acrivon to present ACR-368 endometrial cancer data at ESGO congress
Sunday’s Insider Activity: Top Executives Make Strategic Moves
Acrivon Therapeutics首席执行官Blume-Jensen购入价值8.2万美元股票
Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares
Acrivon Therapeutics首席运营官Devroe购入价值1.7万美元股份
Acrivon Therapeutics COO Devroe buys $17k in shares
派博桑德勒上调Acrivon Therapeutics目标价至8美元,看好癌症数据
Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data
Acrivon Therapeutics股价因癌症试验结果喜忧参半而暴跌
Acrivon Therapeutics stock plunges after mixed cancer trial results
Why Is Acrivon Therapeutics Stock Falling Today? - Acrivon Therapeutics (NASDAQ:ACRV)